Janux Therapeutics, Inc. Common Stock (JANX) is a publicly traded Healthcare sector company. As of May 20, 2026, JANX trades at $14.15 with a market cap of $855.61M and a P/E ratio of -7.74. JANX moved +4.24% today. Year to date, JANX is +4.73%; over the trailing twelve months it is -43.31%. Its 52-week range spans $12.12 to $71.71. Analyst consensus is strong buy with an average price target of $39.79. Rallies surfaces JANX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Janux Therapeutics, Inc. Common Stock (JANX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. JANX moved +4.24% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $14.15 |
| Market Cap | $855.61M |
| P/E Ratio | -7.74 |
| EPS | $-1.84 |
| Dividend Yield | 0.00% |
| 52-Week High | $71.71 |
| 52-Week Low | $12.12 |
| Volume | 931.95K |
| Avg Volume | 0 |
| Revenue (TTM) | $13.73M |
| Net Income | $-114.48M |
| Gross Margin | 0.00% |
15 analysts cover JANX: 0 strong buy, 13 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $39.79.